Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Human growth hormone products recommended for approval

Dec. 16, 1996

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

Encouraging clinical results with MacroChem Rx for impotence

Dec. 13, 1996

Chugai reports new cholesterol-lowering compounds

Dec. 13, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

New hypolipidemic agents claimed by Janssen

Dec. 12, 1996

Scotia drug shows excellent activity in cancer patients with cachexia

Dec. 11, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...